EE200200615A - 1. tüüpi naatrium-vesinikvahetaja inhibiitor (NHE-1) - Google Patents

1. tüüpi naatrium-vesinikvahetaja inhibiitor (NHE-1)

Info

Publication number
EE200200615A
EE200200615A EEP200200615A EEP200200615A EE200200615A EE 200200615 A EE200200615 A EE 200200615A EE P200200615 A EEP200200615 A EE P200200615A EE P200200615 A EEP200200615 A EE P200200615A EE 200200615 A EE200200615 A EE 200200615A
Authority
EE
Estonia
Prior art keywords
nhe
type
sodium hydrogen
hydrogen exchange
exchange inhibitor
Prior art date
Application number
EEP200200615A
Other languages
English (en)
Inventor
George Chen Weichao
David Cox Eric
Guzman-Perez Angel
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of EE200200615A publication Critical patent/EE200200615A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP200200615A 2000-04-28 2001-02-28 1. tüüpi naatrium-vesinikvahetaja inhibiitor (NHE-1) EE200200615A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28
PCT/IB2001/000277 WO2001083470A1 (en) 2000-04-28 2001-02-28 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)

Publications (1)

Publication Number Publication Date
EE200200615A true EE200200615A (et) 2004-04-15

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200615A EE200200615A (et) 2000-04-28 2001-02-28 1. tüüpi naatrium-vesinikvahetaja inhibiitor (NHE-1)

Country Status (40)

Country Link
EP (1) EP1276737A1 (et)
JP (1) JP2003531900A (et)
KR (1) KR20020093079A (et)
CN (1) CN1225466C (et)
AP (1) AP2002002651A0 (et)
AR (1) AR028375A1 (et)
AU (1) AU2001235896A1 (et)
BG (1) BG107139A (et)
BR (1) BR0110268A (et)
CA (1) CA2407535A1 (et)
CO (1) CO5221125A1 (et)
CR (1) CR6797A (et)
CZ (1) CZ20023408A3 (et)
DZ (1) DZ3310A1 (et)
EA (1) EA004882B1 (et)
EE (1) EE200200615A (et)
GT (1) GT200100064A (et)
HN (1) HN2001000042A (et)
HR (1) HRP20020851A2 (et)
HU (1) HUP0300651A2 (et)
IL (1) IL152075A0 (et)
IS (2) IS6567A (et)
MA (1) MA26897A1 (et)
MX (1) MXPA02010600A (et)
MY (1) MY133842A (et)
NO (1) NO20025132L (et)
NZ (1) NZ521348A (et)
OA (1) OA12256A (et)
PA (1) PA8513301A1 (et)
PE (1) PE20011270A1 (et)
PL (1) PL357765A1 (et)
SK (1) SK14872002A3 (et)
SV (1) SV2002000418A (et)
TN (1) TNSN01065A1 (et)
TR (1) TR200202439T2 (et)
UA (1) UA73348C2 (et)
UY (1) UY26680A1 (et)
WO (1) WO2001083470A1 (et)
YU (1) YU79602A (et)
ZA (1) ZA200208605B (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004518686A (ja) * 2001-01-31 2004-06-24 ファイザー・プロダクツ・インク ナトリウム−水素交換輸送体1型阻害剤のエタノラート
EP1456181A1 (en) * 2001-12-19 2004-09-15 Pfizer Products Inc. Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
MXPA04008646A (es) * 2002-05-02 2004-12-06 Pfizer Prod Inc Tratamiento para la diabetes y complicaciones diabeticas con inhibidores del nhe-1.
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
MXPA05008612A (es) * 2003-02-14 2005-12-05 Smithkline Beecham Corp Compuestos novedosos.
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739403B2 (en) * 1998-02-27 2001-10-11 Pfizer Products Inc. N-((substituted five-membered di- or triaza diunsaturated ring)carbonyl) guanidine derivatives for the treatment of ischemia

Also Published As

Publication number Publication date
WO2001083470A1 (en) 2001-11-08
UA73348C2 (en) 2005-07-15
HN2001000042A (es) 2001-07-09
HUP0300651A2 (hu) 2003-07-28
HRP20020851A2 (en) 2005-02-28
JP2003531900A (ja) 2003-10-28
IL152075A0 (en) 2003-05-29
UY26680A1 (es) 2001-12-28
TR200202439T2 (tr) 2003-02-21
SV2002000418A (es) 2002-07-03
SK14872002A3 (sk) 2004-03-02
AR028375A1 (es) 2003-05-07
CN1225466C (zh) 2005-11-02
OA12256A (en) 2003-11-06
CA2407535A1 (en) 2001-11-08
MA26897A1 (fr) 2004-12-20
PA8513301A1 (es) 2003-09-05
EA200201023A1 (ru) 2003-02-27
CO5221125A1 (es) 2002-11-28
PE20011270A1 (es) 2001-12-12
GT200100064A (es) 2002-03-22
CR6797A (es) 2004-05-17
BG107139A (bg) 2003-07-31
NO20025132D0 (no) 2002-10-25
AU2001235896A1 (en) 2001-11-12
IS6567A (is) 2002-09-24
EP1276737A1 (en) 2003-01-22
EA004882B1 (ru) 2004-08-26
PL357765A1 (en) 2004-07-26
KR20020093079A (ko) 2002-12-12
ZA200208605B (en) 2003-10-24
MXPA02010600A (es) 2003-03-10
YU79602A (en) 2006-05-25
DZ3310A1 (fr) 2001-11-07
IS6588A (is) 2002-10-21
AP2002002651A0 (en) 2002-12-31
CZ20023408A3 (cs) 2004-01-14
NO20025132L (no) 2002-12-12
NZ521348A (en) 2004-09-24
BR0110268A (pt) 2003-12-30
TNSN01065A1 (fr) 2005-11-10
MY133842A (en) 2007-11-30
CN1426404A (zh) 2003-06-25

Similar Documents

Publication Publication Date Title
LU93311I2 (fr) Mancozèbe, valifenalate
NO20024395L (no) Niring for diabetikere
DE60131971D1 (de) 1,3,8-TRIAZA-SPIROi4,5 DECAN-4-ONDERIVATIVE ALS NEUROKININREZEPTORANTAGONISTEN
IS6762A (is) Spíró-pýrimídín-2,4,6-tríón málmpróteinasa hindrar
NO20032422L (no) Gass utveksling
DE69935306D1 (de) Verteilte Vermittlungsquerverbindung
DE60101714D1 (de) Wärmetauscher
ID28874A (id) Inhibitor fosfodiesterase 4 turunan ftalazina.
DE60115565D1 (de) Wärmetauscher
ATE309220T1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2- carbonsäurederivate
BR0006509B1 (pt) construção em barra de reação.
AR028248A1 (es) Nuevos compuestos 2,3,4,5-tetrahidro-1h-(1,4) diazepino (1,7-a) indol
EE200200615A (et) 1. tüüpi naatrium-vesinikvahetaja inhibiitor (NHE-1)
BR0214201B1 (pt) sabonete em barra.
IT1318392B1 (it) Composizione getter di idrogeno.
BR0016210B1 (pt) Composição detergente em barra
ITBO990671A0 (it) Maniglione antipanico.
DE60006813D1 (de) Wärmetauscher
ITBO20000495A0 (it) Unita' di trasferimento di articoli.
ATE308460T1 (de) Transfermechanismus
MA26840A1 (fr) Cristaux d'inhibiteur d'echangeur sodium-hydrogene de type 1
DE60102847D1 (de) Wärmetauscher
AR027974A1 (es) 1-aril-ciclopropilmetilamino-1,3,5-triazinas substituidas
ITTO20010387A0 (it) Procedimento di brasatura.
NO20025622D0 (no) Nettverk for dataoverföring